Bank of Montreal’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.76M Buy
159,613
+1,040
+0.7% +$18K ﹤0.01% 1269
2025
Q1
$3.47M Buy
158,573
+77,582
+96% +$1.7M ﹤0.01% 1149
2024
Q4
$2.58M Buy
80,991
+41,635
+106% +$1.33M ﹤0.01% 1282
2024
Q3
$1.16M Sell
39,356
-92,962
-70% -$2.74M ﹤0.01% 1724
2024
Q2
$5.36M Sell
132,318
-619
-0.5% -$25.1K ﹤0.01% 1120
2024
Q1
$7.83M Sell
132,937
-336,947
-72% -$19.8M ﹤0.01% 963
2023
Q4
$29.6M Buy
469,884
+37,911
+9% +$2.39M 0.01% 571
2023
Q3
$19.3M Buy
431,973
+354,047
+454% +$15.8M 0.01% 660
2023
Q2
$7.11M Sell
77,926
-128,622
-62% -$11.7M ﹤0.01% 1030
2023
Q1
$13.9M Buy
206,548
+105,617
+105% +$7.11M 0.01% 736
2022
Q4
$5.22M Sell
100,931
-28,408
-22% -$1.47M ﹤0.01% 1083
2022
Q3
$8.92K Sell
129,339
-38,786
-23% -$2.68K ﹤0.01% 884
2022
Q2
$7.81K Buy
168,125
+18
+0% +$1 ﹤0.01% 986
2022
Q1
$8.33M Sell
168,107
-11,574
-6% -$573K ﹤0.01% 1018
2021
Q4
$8.77M Sell
179,681
-73,847
-29% -$3.6M ﹤0.01% 980
2021
Q3
$8.61M Sell
253,528
-965
-0.4% -$32.8K ﹤0.01% 1261
2021
Q2
$16.3M Buy
254,493
+64,348
+34% +$4.12M 0.01% 959
2021
Q1
$7.9M Buy
190,145
+30,806
+19% +$1.28M 0.01% 1015
2020
Q4
$8.97M Sell
159,339
-183,981
-54% -$10.4M 0.01% 935
2020
Q3
$11.2M Buy
343,320
+8,490
+3% +$276K 0.01% 736
2020
Q2
$10.6M Buy
334,830
+267,330
+396% +$8.48M 0.01% 733
2020
Q1
$1.76M Sell
67,500
-62,768
-48% -$1.64M ﹤0.01% 1335
2019
Q4
$3.99M Buy
130,268
+126,028
+2,972% +$3.86M ﹤0.01% 1274
2019
Q3
$102K Buy
4,240
+192
+5% +$4.62K ﹤0.01% 2811
2019
Q2
$103K Buy
+4,048
New +$103K ﹤0.01% 2875
2019
Q1
Sell
-508
Closed -$7K 3871
2018
Q4
$7K Buy
508
+259
+104% +$3.57K ﹤0.01% 3608
2018
Q3
$4K Sell
249
-7
-3% -$112 ﹤0.01% 3821
2018
Q2
$6K Buy
+256
New +$6K ﹤0.01% 3734